1)大腸癌研究会(編).遺伝性大腸癌診療ガイドライン2020年版.金原出版,2020
2)Vasen HF, van Duijvendijk P, Buskens E, et al. Decision analysis in the surgical treatment of patients with familial adenomatous polyposis:a Dutch-Scandinavian collaborative study including 659 patients. Gut 49:231-235, 2001
3)Ishikawa H, Mutoh M, Iwama T, et al. Endoscopic management of familial adenomatous polyposis in patients refusing colectomy. Endoscopy 48:51-55, 2016
4)Lynch PM, Morris JS, Wen S, et al. A proposed staging system and stage-specific interventions for familial adenomatous polyposis. Gastrointest Endosc 84:115-125, e4, 2016
5)Ishikawa H, Yamada M, Sato Y, et al. Intensive endoscopic resection for downstaging of polyp burden in patients with familial adenomatous polyposis(J-FAPP Study III):a multicenter prospective interventional study. Endoscopy 55:344-352, 2023
6)Takeuchi Y, Hamada K, Nakahira H, et al. Efficacy and safety of intensive downstaging polypectomy(IDP)for multiple duodenal adenomas in patients with familial adenomatous polyposis:a prospective cohort study. Endoscopy 55:515-523, 2023
7)石川秀樹.家族性大腸腺腫症における大腸癌の予防.日消誌 113:1191-1195, 2016
8)Burn J, Bishop DT, Chapman PD, et al. A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis. Cancer Prev Res(Phila) 4:655-665, 2011
9)Ishikawa H, Mutoh M, Sato Y, et al. Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy(J-FAPP Study IV):a multicentre, double-blind, randomised, two-by-two factorial design trial. Lancet Gastroenterol Hepatol 6:474-481, 2021
10)McNeil JJ, Wolfe R, Woods RL, et al. Effect of aspirin on cardiovascular events and bleeding in the healthy elderly. N Engl J Med 379:1509-1518, 2018
11)Sugawara M, Goto Y, Yamazaki T, et al. Low-dose aspirin for primary prevention of cardiovascular events in elderly Japanese patients with atherosclerotic risk factors:Subanalysis of a Randomized Clinical Trial(JPPP-70). Am J Cardiovasc Drugs 19:299-311, 2019